Cell cycle phase specificity of antitumor agents.
D000470:Alkaloids / Q000494:pharmacology; D000477:Alkylating Agents / Q000494:pharmacology; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002227:Carbazoles / Q000494:pharmacology; D002460:Cell Line / Q000187:drug effects*; D002699:Chlorambucil / Q000494:pharmacology; D006224:Cricetinae; D003561:Cytarabine / Q000494:pharmacology; D004247:DNA / Q000096:biosynthesis; D003609:Dactinomycin / Q000494:pharmacology; D003864:Depression, Chemical; D005347:Fibroblasts; D005467:Floxuridine / Q000494:pharmacology; D066298:In Vitro Techniques; D008168:Lung; D008558:Melphalan / Q000494:pharmacology; D008938:Mitosis / Q000187:drug effects*; D009374:Neoplasms, Experimental / Q000188:drug therapy; D009607:Nitrosourea Compounds / Q000494:pharmacology; D009705:Nucleosides / Q000494:pharmacology; D014176:Protein Biosynthesis; D012313:RNA / Q000096:biosynthesis; D013311:Streptozocin / Q000494:pharmacology; D013882:Thiosemicarbazones / Q000494:pharmacology
D000470:Alkaloids; D000477:Alkylating Agents; D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D002227:Carbazoles; D009607:Nitrosourea Compounds; D009705:Nucleosides; D013882:Thiosemicarbazones; D005467:Floxuridine; D003561:Cytarabine; D002699:Chlorambucil; D003609:Dactinomycin; D013311:Streptozocin; D012313:RNA; D004247:DNA; D008558:Melphalan